GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hofseth BioCare ASA (OTCPK:HOFBF) » Definitions » EPS (Diluted)

Hofseth BioCare ASA (Hofseth BioCare ASA) EPS (Diluted) : $-0.02 (TTM As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Hofseth BioCare ASA EPS (Diluted)?

Hofseth BioCare ASA's Earnings per Share (Diluted) for the three months ended in Mar. 2024 was $-0.01. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.02.

Hofseth BioCare ASA's EPS (Basic) for the three months ended in Mar. 2024 was $-0.01. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.02.

Hofseth BioCare ASA's EPS without NRI for the three months ended in Mar. 2024 was $-0.01. Its EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.02.

During the past 3 years, the average EPS without NRIGrowth Rate was -2.10% per year. During the past 5 years, the average EPS without NRI Growth Rate was -2.70% per year. During the past 10 years, the average EPS without NRI Growth Rate was 9.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Hofseth BioCare ASA's highest 3-Year average EPS without NRI Growth Rate was 54.20% per year. The lowest was -64.20% per year. And the median was -2.50% per year.


Hofseth BioCare ASA EPS (Diluted) Historical Data

The historical data trend for Hofseth BioCare ASA's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hofseth BioCare ASA EPS (Diluted) Chart

Hofseth BioCare ASA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.03 -0.04 -0.04 -0.04 -0.03

Hofseth BioCare ASA Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.01 - -0.01 -0.01 -0.01

Competitive Comparison of Hofseth BioCare ASA's EPS (Diluted)

For the Biotechnology subindustry, Hofseth BioCare ASA's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hofseth BioCare ASA's PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hofseth BioCare ASA's PE Ratio distribution charts can be found below:

* The bar in red indicates where Hofseth BioCare ASA's PE Ratio falls into.



Hofseth BioCare ASA EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Hofseth BioCare ASA's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-10.113-0)/395.081
=-0.03

Hofseth BioCare ASA's Diluted EPS for the quarter that ended in Mar. 2024 is calculated as

Diluted EPS (Q: Mar. 2024 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-2.733-0)/411.549
=-0.01

EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hofseth BioCare ASA  (OTCPK:HOFBF) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Hofseth BioCare ASA EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Hofseth BioCare ASA's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Hofseth BioCare ASA (Hofseth BioCare ASA) Business Description

Traded in Other Exchanges
Address
Kipervikgata 13, Aalesund, NOR, 6003
Hofseth BioCare ASA is a Norway based company engaged in the business of development, manufacturing, marketing and sale of marine ingredients such as oil, calcium and protein products. It is also involved in cooperation, participation, and ownership in the businesses engaged in related activities. The group operates in the business segment of producing salmon oil, soluble protein, calcium, and nonwater soluble protein. The brands under the company are OmeGo, PetGo, ProGo, and CalGo. The firm sells products to various segments of the human nutrition market such as sports nutrition, supplements, and health foods, as well as to the market within nutrition to pet and feed industry. It generates the majority of the revenue from the sale of salmon oil internationally.

Hofseth BioCare ASA (Hofseth BioCare ASA) Headlines